Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anirban Lahiry"'
Autor:
Odd Erik Johansen, Joel Neutel, Sanjay Gupta, Barbara Mariani, Gerhard Ufheil, Emilie Perrin, Andreas Rytz, Anirban Lahiry, Frederik Delodder, Jaclyn Lerea-Antes, Naomi Ocampo, Maximilian von Eynatten
Publikováno v:
Metabolites, Vol 14, Iss 8, p 410 (2024)
We assessed the glucometabolic effects of oligomalt, a novel fully slowly digestible carbohydrate, compared with maltodextrin, in cross-over randomized controlled trials (NCT05058144; NCT05963594) involving healthy volunteers (HV), people with overwe
Externí odkaz:
https://doaj.org/article/540a6092186d4bc08ad34ca770cb9fad
Autor:
Odd Erik Johansen, Delphine Curti, Maximilian von Eynatten, Andreas Rytz, Anirban Lahiry, Frederik Delodder, Gerhard Ufheil, Carmine D’Urzo, Audrey Orengo, Kate Thorne, Jaclyn S. Lerea-Antes
Publikováno v:
Nutrients, Vol 15, Iss 12, p 2752 (2023)
In this randomized, double-blind triple-crossover study (NCT05142137), the digestive tolerance and safety of a novel, slowly digestible carbohydrate (SDC), oligomalt, an α-1,3/α-1,6-glucan α-glucose-based polymer, was assessed in healthy adults ov
Externí odkaz:
https://doaj.org/article/a43607ea646e44f19a0feda0e0fc66e9
Autor:
Lerea-Antes, Odd Erik Johansen, Delphine Curti, Maximilian von Eynatten, Andreas Rytz, Anirban Lahiry, Frederik Delodder, Gerhard Ufheil, Carmine D’Urzo, Audrey Orengo, Kate Thorne, Jaclyn S.
Publikováno v:
Nutrients; Volume 15; Issue 12; Pages: 2752
In this randomized, double-blind triple-crossover study (NCT05142137), the digestive tolerance and safety of a novel, slowly digestible carbohydrate (SDC), oligomalt, an α-1,3/α-1,6-glucan α-glucose-based polymer, was assessed in healthy adults ov
Autor:
Anirban Lahiry, Neha Shah, David Belada, B. Brackertz, Petra Pichler, Katerina Kopeckova, E. Lohrmann, Pia Klöpfer, Wolfram Brugger, Grzegorz S. Nowakowski, John M. Burke, J. M Bergua Burgues, E. Pérez Persona, Marc André
Publikováno v:
Hematological Oncology. 39
Background: Tafasitamab is a humanized, Fc-modified anti-CD19 monoclonal antibody that enhances antibody-dependent cellular cytotoxicity and phagocytosis. It is FDA-approved in combination with lenalidomide for adult patients with relapsed/refractory
Autor:
Stephen J. Baker, Nathalie Hopchet, Jeremy Dennison, Graeme Young, Shuying Yang, Andrew W Harrell, Andy Gillies, Amanda Oliver, Frans van den Berg, David C Starbuck, Etienne Dumont, Vijayalakshmi Chandrasekaran, Anirban Lahiry, Alex Georgiou, Chris Ioannou, Julia Billiard
Publikováno v:
Antimicrobial Agents and Chemotherapy
Chronic obstructive pulmonary disease (COPD) is an inflammatory lung condition, causing progressive decline in lung function leading to premature death. Acute exacerbations in COPD patients are predominantly associated with respiratory viruses. Ribav
Autor:
Marek Trněný, Juan Miguel Bergua Burgues, Anirban Lahiry, John M. Burke, Pia Klöpfer, Marc André, Grzegorz S. Nowakowski, Petra Pichler, Wolfram Brugger, Emanuel Lohrmann, Günter Fingerle-Rowson, Don A. Stevens, David Belada, Katerina Kopeckova, Bettina Brackertz, Ernesto Pérez Persona, Neha Shah
Publikováno v:
Blood. 136:27-28
Introduction Approximately 15-20% of treatment-naïve patients with diffuse large B-cell lymphoma (DLBCL) have CD20-low tumors, while CD19 is homogeneously expressed in >90% of cases of DLBCL. CD20-low DLBCL is associated with poor response to rituxi